Seoul National University Hospital
Seoul, South Korea
NCT Number: NCT01914432
To evaluate efficacy and safety of YH16410 versus rosuvastatin and telmisartan monotherapies in patients with hypertension and hyperlipidemia
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Phase 3
Seoul, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Change from Baseline at 8 weeks
Yuhan Corporation
Industry
A Double-blind, Randomized, Multi-center Phase III Clinical Trial to Investigate the Safety and Efficacy Between YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01764178
Cardiovascular Diseases, Dyslipidemias
Seoul, South Korea
View Trial DetailsNCT06486532
Cardiovascular Diseases, Dyslipidemias
Saint Louis Park, Minnesota, United States
View Trial DetailsNCT04977583
Cardiovascular Disease, Cardiovascular Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06543706
Body Weight, Brain Diseases
Beijing, Beijing Municipality, China
View Trial Details